FDA | Press Releases
Follow
FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide
The U.S. Food and Drug Administration today approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection for weight loss and long-term maintenance of weight loss for certain adult patients.
